Benefits of EDTA Chelation Therapy in Arteriosclerosis: A Retrospective
Study of 470 Patients

C. Hancke, MD and K. Flytlie, MD

Claus Hancke M.D. received his medical education at the University of Copenhagen. He is general practice and is president of the Danish Chelation Doctors. He is an ABCT diplomate. Knut Flytlie M.D. received his medical education at the University of Gutenberg, Germany. He is in general practice and operates a clinic for Preventive Medicine and Chelation. He is an ABCT diplomate.

ABSTRACT: In a retrospective study we report results of EDTA chelation in 470 patients, using a number of parameters, most of them objective. Although the patients acted as their own controls, we observed improvements of 80 to 90%, depending upon the measurement used. Of 92 patients referred for surgical intervention, only 10 required ultimate surgery after or during their chelation therapy, thus saving an estimated 3 million dollars of insurance money. Our experience covers a period of 6 years and we saw no severe side effects or casualties arising from the treatment. We conclude that EDTA chelation therapy is safe, effective and cost-saving.

Journal of Advancement in Medicine Volume 6, Number 3, Fall 1993
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

BACK TO CHELATION RESEARCH

BACK TO MAIN CHELATION PAGE

Mount Rainier Clinic
503 First Street South, Suite 1
Yelm, Washington 98597, USA

Telephone: (360) 458-1061
FAX: (360) 458-1661

email: Click here to send us an email message

Copyright © 2007 John A. Cranton, ARNP, all rights reserved

Last modified:                                           Disclaimer